Analysts Set Bicara Therapeutics Inc. (NASDAQ:BCAX) PT at $31.86
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation […]
Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) has been given an average recommendation of “Buy” by the nine ratings firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation […]
